TELA Bio, Inc.TELA

Health Care · Health Care Equipment & Services · NASDAQ · United States · telabio.com

TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The company provides surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the body's natural healing response while minimizing long-term exposure to permanent synthetic materials.

Key ratios

FCF / Sales

-39.6%TTM

2025 -35.7%2024 -61.4%2023 -70.9%

Net margin

-51.5%TTM

2025 -48.4%2024 -54.6%2023 -79.8%

ROA

-25.1%2025

2024 -31.7%2023 -37.8%

ROE

-223.4%2025

2024 -159.9%2023 -281.2%

Revenue growth

6.1%TTM

2025 15.8%2024 18.6%2023 41.1%

Recent news

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative 2026-08-31 · GlobeNewswire

Track TELA in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer